Y. Ueno

发表

MK-2206, an Allosteric Akt Inhibitor, Enhances Antitumor Efficacy by Standard Chemotherapeutic Agents or Molecular Targeted Drugs In vitro and In vivo

P. Majumder, Hiroshi Sootome, H. Hirai, 2010, Molecular Cancer Therapeutics.

Activation of MEK/ERK and PI3K/Akt pathways by fibronectin requires integrin αv‐mediated ADAM activity in hepatocellular carcinoma: A novel functional target for gefitinib

H. Sakurai, I. Saiki, Y. Ueno, 2006, Cancer science.

Effect of Fms-like tyrosine kinase 3 (FLT3) ligand (FL) on antitumor activity of gilteritinib, a FLT3 inhibitor, in mice xenografted with FL-overexpressing cells

Tomoyuki Suzuki, Taku Yoshida, T. Eguchi, 2019, Oncotarget.

Gilteritinib, a FLT3/AXL inhibitor, shows antileukemic activity in mouse models of FLT3 mutated acute myeloid leukemia

K. Mori, S. Kuromitsu, Y. Ueno, 2017, Investigational New Drugs.

Selective M3 muscarinic receptor antagonist inhibits small-cell lung carcinoma growth in a mouse orthotopic xenograft model.

Y. Ueno, H. Ohta, Y. Ogino, 2011, Journal of pharmacological sciences.

Enhancement of the antitumor effect of gamma-ray irradiation in combination with camptothecin against human colorectal adenocarcinoma.

Y. Ueno, H. Oyamada, S. Kojima, 1996, Biological & pharmaceutical bulletin.

Anti-tumor activity of T-2 toxin-conjugated A7 monoclonal antibody (T-2-A7 MoAb) against human colon carcinoma.

T. Yamaguchi, Y. Ueno, S. Kojima, 1993, Natural toxins.

The Cell Cycle-Specific Growth-Inhibitory Factor Produced by Actinobacillus actinomycetemcomitansIs a Cytolethal Distending Toxin

É. Oswald, Y. Ueno, M. Sugai, 1998, Infection and Immunity.

Gilteritinib (ASP2215), a Novel FLT3/AXL Inhibitor: Preclinical Evaluation in Combination with Azacitidine in Acute Myeloid Leukemia

Y. Ueno, N. Kaneko, Y. Kamiyama, 2016 .

Evaluation of gilteritinib in combination with chemotherapy in preclinical models of FLT3-ITD+ acute myeloid leukemia

S. Kuromitsu, Y. Ueno, N. Kaneko, 2019, Oncotarget.

Biogenesis of the Actinobacillus actinomycetemcomitans Cytolethal Distending Toxin Holotoxin

É. Oswald, Y. Ueno, M. Sugai, 2006, Infection and Immunity.

Abstract 866: ASP3026, a selective ALK inhibitor, induces tumor regression in a crizotinib-refractory model and prolongs survival in an intrapleurally xenograft model

S. Kuromitsu, Y. Ueno, R. Tanaka, 2012 .

Abstract A227: Antitumor activities of ASP3026 against EML4-ALK-dependent tumor models.

H. Mano, M. Sasamata, N. Shindoh, 2011 .

Inhibitory effects of mycotoxins on the protein synthesis in rabbit reticulocytes.

Y. Ueno, M. Hosoya, Y. Ishikawa, 1969, Journal of biochemistry.

The Selective Anaplastic Lymphoma Receptor Tyrosine Kinase Inhibitor ASP3026 Induces Tumor Regression and Prolongs Survival in Non–Small Cell Lung Cancer Model Mice

K. Mori, S. Kuromitsu, Y. Ueno, 2014, Molecular Cancer Therapeutics.

Comparative study on skin-necrotizing effect of scirpene metabolites of Fusaria.

Y. Ueno, M. Saito, Y. Ishikawa, 1970, The Japanese journal of experimental medicine.

Transient Suppression of Ligand-mediated Activation of Epidermal Growth Factor Receptor by Tumor Necrosis Factor-α through the TAK1-p38 Signaling Pathway*

Hiroaki Sakurai, H. Sakurai, I. Saiki, 2007, Journal of Biological Chemistry.

Heregulin‐induced activation of ErbB3 by EGFR tyrosine kinase activity promotes tumor growth and metastasis in melanoma cells

Hiroaki Sakurai, Keiichi Koizumi, H. Sakurai, 2008, International journal of cancer.

Toxicological approaches to the metabolites of Fusaria. VII. Effects of zearalenone on the uteri of mice and rats.

Y. Ueno, M. Enomoto, S. Yagasaki, 1974, Chemical & pharmaceutical bulletin.

Toxicological approaches to the metabolites of Fusaria. X. Accelerating effect of zearalenone on RNA and protein syntheses in the uterus of ovariectomized mice.

Y. Ueno, Y Ueno, S Yagasaki, 1975, The Japanese journal of experimental medicine.

Toxicological approaches to the metabolites of Fusaria. II. Isolation of fusarenon-X from the culture filtrate of Fusarium nivale Fn 2B.

Y. Ueno, I. Ueno, H. Tsunoda, 1971, The Japanese journal of experimental medicine.

Environmental factors influencing the production of fusarenon-X, a cytotoxic mycotoxin of Fusarium nivale Fn 2B.

Y. Ueno, Y. Ueno, H. Tsunoda, 1970, Chemical & pharmaceutical bulletin.

An N-terminal Segment of the Active Component of the Bacterial Genotoxin Cytolethal Distending Toxin B (CDTB) Directs CDTB into the Nucleus*

É. Oswald, Y. Ueno, M. Ikura, 2003, Journal of Biological Chemistry.

Selective inhibition of TNF-α-induced activation of mitogen-activated protein kinases and metastatic activities by gefitinib

H. Sakurai, M. Choo, I. Saiki, 2005, British Journal of Cancer.

Prevalence of Cytolethal Distending Toxin Production in Periodontopathogenic Bacteria

K. Okuda, K. Tanne, É. Oswald, 2003, Journal of Clinical Microbiology.

Bacteria Production in Periodontopathogenic Prevalence of Cytolethal Distending Toxin

K. Okuda, K. Tanne, É. Oswald, 2003 .

Massive T-lymphocyte infiltration into the host stroma is essential for fibroblast growth factor-2-promoted growth and metastasis of mammary tumors via neovascular stability.

H. Sakurai, I. Saiki, Y. Ueno, 2009, The American journal of pathology.

Cytotoxic Necrotizing Factor Type 2 Produced by Pathogenic Escherichia coli Deamidates a Gln Residue in the Conserved G-3 Domain of the Rho Family and Preferentially Inhibits the GTPase Activity of RhoA and Rac1

H. Ohta, É. Oswald, Y. Ueno, 1999, Infection and Immunity.

Biogenesis of Actinobacillus actinomycetemcomitans Cdt holotoxin

É. Oswald, Y. Ueno, M. Sugai, 2007 .

ASP2215, a novel FLT3/AXL inhibitor: Preclinical evaluation in acute myeloid leukemia (AML).

S. Kuromitsu, Y. Ueno, N. Kaneko, 2014 .